A phase 1, randomized, double-blind, placebo-controlled, sequential-panel, ascending single-dose study to evaluate the safety, tolerability, and pharmacokinetics of intravenous CMX-020 in healthy male and female subjects
A Randomized, Double-Blind, Placebo-Controlled Crossover Study to Evaluate the Analgesic Efficacy and Safety of Oral CMX-020 in Subjects with Symptoms of Sciatica Resulting from Lumbosacral Radiculopathy.
100 项与 Cytometix, Inc. 相关的临床结果
0 项与 Cytometix, Inc. 相关的专利(医药)
100 项与 Cytometix, Inc. 相关的药物交易
100 项与 Cytometix, Inc. 相关的转化医学